BLALOCK, WILLIAM
 Distribuzione geografica
Continente #
AS - Asia 686
NA - Nord America 403
EU - Europa 184
SA - Sud America 110
AF - Africa 16
Totale 1.399
Nazione #
US - Stati Uniti d'America 384
SG - Singapore 289
CN - Cina 176
BR - Brasile 89
VN - Vietnam 65
HK - Hong Kong 61
IT - Italia 60
FR - Francia 35
KR - Corea 32
FI - Finlandia 30
JP - Giappone 14
NL - Olanda 12
DE - Germania 11
GB - Regno Unito 10
AR - Argentina 9
BD - Bangladesh 9
ZA - Sudafrica 8
CA - Canada 7
IN - India 6
MX - Messico 6
IL - Israele 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IQ - Iraq 4
PL - Polonia 4
ID - Indonesia 3
RU - Federazione Russa 3
AT - Austria 2
ES - Italia 2
IE - Irlanda 2
PK - Pakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MZ - Mozambico 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.399
Città #
Singapore 173
Santa Clara 160
Hefei 78
Hong Kong 59
Ashburn 40
Beijing 40
Pavia 33
Seoul 32
Lauterbourg 31
San Jose 29
Los Angeles 25
Ho Chi Minh City 24
São Paulo 15
Hanoi 14
Helsinki 13
Lappeenranta 10
Tokyo 9
New York 7
Turku 7
Orem 5
Bologna 4
Falkenstein 4
Frankfurt am Main 4
Minamishinagawa 4
Phoenix 4
Warsaw 4
Abu Dhabi 3
Atlanta 3
Buffalo 3
Chicago 3
Johannesburg 3
Rio de Janeiro 3
Ankara 2
Bengaluru 2
Can Tho 2
Cape Town 2
Council Bluffs 2
Denver 2
Dublin 2
Erbil 2
Fortaleza 2
Guayaquil 2
Haiphong 2
Houston 2
Hải Dương 2
Istanbul 2
Las Vegas 2
London 2
Montevideo 2
Montreal 2
Mumbai 2
Munich 2
Phương Lâm 2
Piscataway 2
Quito 2
Rome 2
San Francisco 2
Sarzedo 2
Tel Aviv 2
Thái Nguyên 2
Turin 2
Abakan 1
Accra 1
Adel 1
Alcobendas 1
Almaty 1
Alvignano 1
Amman 1
Amsterdam 1
Angra dos Reis 1
Aracaju 1
Araçatuba 1
Athens 1
Aurora 1
Bady Bassitt 1
Baixo Guandu 1
Baku 1
Balsas 1
Barnet 1
Barquisimeto 1
Basra 1
Bedford 1
Bekasi 1
Belo Horizonte 1
Bhubaneswar 1
Biên Hòa 1
Bogor 1
Bolton 1
Boston 1
Brakpan 1
Bridgetown 1
Brooklyn 1
Buenos Aires 1
Bến Cầu 1
Cairo 1
Calgary 1
Cambuí 1
Campo Grande 1
Campos do Jordão 1
Caracas 1
Totale 943
Nome #
Intolerant contact lens wearers exhibit ocular surface impairment despite 3 months wear discontinuation 77
Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells 72
Mineralocorticoid receptor antagonism prevents type 2 Familial Partial Lipodystrophy brown adipocyte dysfunction 71
Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells 67
Cancer therapy and treatments during COVID-19 era 62
Revisiting the role of GSK3, a modulator of innate immunity, in idiopathic inclusion body myositis 61
Nuclear PI-PLCbeta1: An appraisal on targets and pathology 60
Ectopic expression of Ankrd2 affects proliferation, motility and clonogenic potential of human osteosarcoma cells 60
A rapid standardized quantitative microfluidic system approach for evaluating human tear proteins. 59
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling 59
Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion. 54
Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing 54
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response 50
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells 50
Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad 48
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 46
Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function Preservation 46
Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches 45
AKT-Dependent Phosphorylation of ADAR1p110 and ADAR2 Represents a New and Important Link Between Cell Signaling and RNA Editing 45
AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity. 44
Innate Immunity: A Balance between Disease and Adaption to Stress 41
MiRNA-210: A Current Overview 40
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204 39
RNA processing and ribosome biogenesis in bone marrow failure disorders 38
Cell cycle arrest and apoptosis induced by kinamycin f in human osteosarcoma cells 37
Opposing forces fight over the same ground to regulate interferon signaling. 31
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells 29
Identification of the PKR nuclear interactome reveals roles in ribosome biogenesis, mRNA processing and cell division 28
BMP-2 Induced Expression of PLCbeta1 That Is a Positive Regulator of Osteoblast Differentiation. 27
PLCbeta1a and PLCbeta1b selective regulation and cyclin D3 modulation reduced by Kinamycin F during K562 cell differentiation. 24
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C betaI. 22
A role for PLCbeta1 in myotonic dystrophies type 1 and 2 22
Totale 1.508
Categoria #
all - tutte 4.813
article - articoli 4.813
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20242 0 0 0 0 0 0 0 0 0 0 1 1
2024/2025707 2 1 43 18 145 120 9 55 56 13 140 105
2025/2026799 49 69 63 150 170 39 118 34 29 49 29 0
Totale 1.508